Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
PLoS Med
    October 2020
  1. MAHAJAN UV, Varma VR, Griswold ME, Blackshear CT, et al
    Correction: Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
    PLoS Med. 2020;17:e1003439.
    >> Share

    August 2020
  2. SADDIKI H, Fayosse A, Cognat E, Sabia S, et al
    Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
    PLoS Med. 2020;17:e1003289.
    >> Share

    January 2020
  3. MAHAJAN UV, Varma VR, Griswold ME, Blackshear CT, et al
    Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
    PLoS Med. 2020;17:e1003012.
    >> Share

    September 2018
  4. LIM ASP, Gaiteri C, Yu L, Sohail S, et al
    Seasonal plasticity of cognition and related biological measures in adults with and without Alzheimer disease: Analysis of multiple cohorts.
    PLoS Med. 2018;15:e1002647.
    >> Share

  5. LAWLOR B, Segurado R, Kennelly S, Olde Rikkert MGM, et al
    Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.
    PLoS Med. 2018;15:e1002660.
    >> Share

    February 2018
  6. JOBKE B, McBride T, Nevin L, Peiperl L, et al
    Setbacks in Alzheimer research demand new strategies, not surrender.
    PLoS Med. 2018;15:e1002518.
    >> Share

    January 2018
  7. VARMA VR, Oommen AM, Varma S, Casanova R, et al
    Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
    PLoS Med. 2018;15:e1002482.
    >> Share

    April 2017
  8. WHITE CC, Yang HS, Yu L, Chibnik LB, et al
    Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data.
    PLoS Med. 2017;14:e1002287.
    >> Share

    March 2017
  9. BENNETT DA
    Mixed pathologies and neural reserve: Implications of complexity for Alzheimer disease drug discovery.
    PLoS Med. 2017;14:e1002256.
    >> Share

  10. DESIKAN RS, Fan CC, Wang Y, Schork AJ, et al
    Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.
    PLoS Med. 2017;14:e1002258.
    >> Share

  11. PIERCE AL, Kawas CH
    Dementia in the oldest old: Beyond Alzheimer disease.
    PLoS Med. 2017;14:e1002263.
    >> Share

  12. SNOWDEN SG, Ebshiana AA, Hye A, An Y, et al
    Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study.
    PLoS Med. 2017;14:e1002266.
    >> Share

  13. LANOISELEE HM, Nicolas G, Wallon D, Rovelet-Lecrux A, et al
    APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
    PLoS Med. 2017;14:e1002270.
    >> Share

  14. STEELE NZ, Carr JS, Bonham LW, Geier EG, et al
    Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: A case-control study.
    PLoS Med. 2017;14:e1002272.
    >> Share


  15. Correction: Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.
    PLoS Med. 2017;14:e1002289.
    >> Share

  16. SUEMOTO CK, Ferretti-Rebustini RE, Rodriguez RD, Leite RE, et al
    Neuropathological diagnoses and clinical correlates in older adults in Brazil: A cross-sectional study.
    PLoS Med. 2017;14:e1002267.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016